Clinical Trials Browser

Phase 2 × Carcinoma, Neuroendocrine × belinostat × Clear all

NCT06406465 2026-06-05

A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity

Phase 2 Recruiting

Carcinoma, Neuroendocrine, Neuroendocrine Tumors